Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g a...

FDA Drug Recall #D-0452-2022 — Class II — January 21, 2022

Recall Summary

Recall Number D-0452-2022
Classification Class II — Moderate risk
Date Initiated January 21, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mylan Pharmaceuticals Inc
Location Morgantown, WV
Product Type Drugs
Quantity 233,199/10 g aerosol containers

Product Description

Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.

Reason for Recall

cGMP deficiencies

Distribution Pattern

Recalled product was distributed nationwide within the United States.

Lot / Code Information

Lot #: 32925, Exp. date May 2023, 33010, Exp. date June 2023; 33119, 33123, Exp. date August 2023

Other Recalls from Mylan Pharmaceuticals Inc

Recall # Classification Product Date
D-0399-2026 Class II Isotretinoin Capsules, USP 40 mg, packaged in 3... Feb 24, 2026
D-0280-2025 Class II Prasugrel Tablets, USP, 5 mg, 30-count bottle, ... Feb 25, 2025
D-1292-2022 Class I Insulin Glargine (Insulin glargine-yfgn) Inject... Jul 5, 2022
D-0845-2022 Class I Insulin Glargine (insulin glargine-yfgn) Inject... Apr 12, 2022
D-0774-2022 Class II Rifampin for Injection, USP, 600 mg/vial, One V... Apr 7, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.